Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Paralysis'  (Integration tree)

Pathogenesis

• Genetic disorders of glycan degradation

Disorders by systems

• Genetic disorders of glycan degradation (by systems, signs and symptoms)
  • Diseases
    • Nervous System Diseases
      • Neurologic Manifestations
        • Paralysis
          • Morquio syndrome A (GDGDB) [GALNS]
          • Morquio syndrome B (GDGDB) [GLB1]
          • Tay-Sachs disease (GDGDB) [HEXA]
          • Sandhoff disease (GDGDB) [HEXB]
          • GM2-gangliosidosis, AB variant (GDGDB) [GM2A]
          • Metachromatic leukodystrophy (GDGDB) [ARSA]
          • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
            • Farber Lipogranulomatosis, type 5 [ASAH1]
          • Facial Paralysis
            • Niemann-Pick disease, type C1 (GDGDB) [NPC1]
            • Niemann-Pick disease, type C2 (GDGDB) [NPC2]